Latest filing published 30 Dec 2025 for Arrowhead Pharmaceuticals, INC., €447k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Mauro Ferrari in Arrowhead Pharmaceuticals, Inc., where the filings describe the role as board member. Over a trading history stretching from 28 December 2021 to 26 December 2025, the count stands at 10 filings.
The open-market record consists of 5 sales worth €1.2M, with no purchase. Besides market trades, the filings include 5 share grants. So far in 2025, the count stands at no purchases and 2 sales.
Most recently, on 30 December 2025, the filings show an open-market sale worth €447k in Arrowhead Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations